R. Perret

Type de document

Co-auteur

P. Romero

A. Donda

L. Zhang

J.P. Mach

S. CORGNAC

D. Zehn

M. Zauderer

D.T. Utzschneider

K. Stirnemann

D.E. Speiser

B. Salaun

N. Rufer

N.P. Restifo

D.C. Palmer

S.A. Muljo

G.C. Monnot

E. Merck

Y. Ji

W. Held

M. Hebeisen

L. Gattinoni

T.M. Escobar

J.C. Dudda

L. Derré

C. Boudousquie

Date

Source

Serveur académique Lausannois (3)

Mot-clé

cancer (3) Cancer (3) Cells (3) Cancer (3) protéine (2) immunité (2) T cells (2) Mice (2) Killer cells (2) Inhibition (2) Immunotherapy (2) Immunity (2) Fusion (2) Immunotherapy (2) administration (1) puits (1) virus (1) additif (1) thérapie (1) état (1) anticorps (1) infection (1) évaluation (1) Context (1) Treatment (1) Control (1) Agonists (1) Methods (1) Dendritic cells (1) Tumors--Growth (1)

Documents écrit par R. Perret (3) | parle de R. Perret (2)

iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine.

S. Corgnac et al. (2014)

MicroRNA-155 Is Required for Effector CD8(+) T Cell Responses to Virus Infection and Cancer.

J.C. Dudda et al. (2013)

CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.

S. Corgnac et al. (2013)